Showing results (71-80 of 375) with videos related to
Sort By:
Pageof 38
Clinical Nuclear Medicine|August 9, 2016
68Ga DOTATATE PET/CT in Differentiated Thyroid Carcinoma With Fibular Metastasis and Mixed Response to SorafenibSandip Basu, Amit JoshiClinical Nuclear Medicine|June 5, 2026
Theranostics and Molecular-targeted Endo-radiotherapy: The Current Landscape and Future DirectionsAamir Nazar, Sandip BasuDiagnostics (Basel, Switzerland)|January 8, 2023
PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research ApplicationsAadil Adnan, Sandip BasuJournal of Nuclear Medicine Technology|September 6, 2014
The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATESandip Basu, Amit AbhyankarJournal of Cancer Research and Therapeutics|October 14, 2015
Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practiceAmit Abhyankar, Sandip BasuJournal of Nuclear Medicine Technology|August 12, 2019
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with <sup>177</sup>Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide TherapyAadil Adnan, Sandip BasuClinical Nuclear Medicine|September 15, 2004
Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: hepatic 'superscan'Sandip Basu, Narendra NairPET Clinics|May 8, 2025
PET-based Quantitative Techniques in Assessing Efficacy of Interventional Radiology Procedures in OncologyAadil Adnan, Sandip BasuJournal of Nuclear Medicine Technology|October 26, 2013
The added clinical value of 18F-FDG PET/CT in evaluating intratracheal recurrence of differentiated thyroid carcinoma: implications for planning surgery, assessing its completeness, and planning radioiodine therapySandip Basu, Amit AbhyankarWorld Journal of Nuclear Medicine|January 15, 2020
Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography (<sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-fluorodeoxyglucose) molecular imaging and disease stabilization following <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapySonali Jadhav, Sandip BasuPageof 38